Dr. Byrnes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 NW 16th St
D1010
Miami, FL 33125Phone+1 305-575-3143Fax+1 305-575-3375
Summary
- Dr. John Byrnes is an oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including University of Miami Hospital and University of Miami Hospital and Clinics. He received his medical degree from Tufts University School of Medicine and has been in practice 49 years. He is experienced in amyloidosis, hematologic oncology, thrombotic microangiopathy, myelodysplasia, and myelofibrosis. He has more than 40 publications and over 500 citings.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1970 - 1973
University at BuffaloResidency, Internal Medicine, 1969 - 1970- University at Buffalo School of MedicineInternship, Transitional Year, 1968 - 1969
Tufts University School of MedicineClass of 1968
Certifications & Licensure
FL State Medical License 1973 - 2026
MD State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Diagnostic Laboratory Immunology
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 1983
Publications & Presentations
PubMed
- 241 citationsRandomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM TrialJoshua M. Hare, Darcy L. DiFede, Angela C. Rieger, Victoria Florea, Ana Marie Landin
Journal of the American College of Cardiology. 2017-02-07 - 248 citationsAutologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing ...Vasileios Karantalis, Darcy L. DiFede, Gary Gerstenblith, Si M. Pham, James F Symes
Circulation Research. 2014-04-11 - 405 citationsTransendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy The TAC-HFT Randomized TrialAlan W. Heldman, Darcy L. DiFede, Joel E. Fishman, Juan P. Zambrano, Barry H. Trachtenberg
JAMA. 2014-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
